Innovation
5 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 194 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Social engagement
Social engagement: 2.1K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Europa, Harel Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Accelerator & incubator | 1 | 7% |
| Other / undisclosed | 5 | 36% |
Recent activity
9 May 2026
Event
Anti-infective session
7 Apr 2026
Event
Targeting Sepsis via LPS Neutralization - Therapeutic Potential of OMN6
16 Feb 2026
Event
AMR Conference